Most mitochondrial proteins are synthesized in the cytosol and must be imported into the mitochondria. Many mitochondrial precursor proteins have an extra leader sequence at their N-terminus called a presequence. Presequences are recognized by the Tom20 receptor protein. Based on the previously determined NMR structure of rat Tom20, a fragment corresponding to the core structure was generated. A cysteine residue was added at the C-terminus of the rat aldehyde dehydrogenase presequence to fix the presequence peptide onto the Tom20 fragment via an intermolecular disulfide bond. Two crystal forms of the complex were successfully obtained with different designs of the linker sequence which diffracted to 2.1 and 1.9 Å . Crystal dehydration and subsequent annealing was essential to obtain good diffraction data for the 2.1 Å crystal form.
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Crystallization and preliminary X-ray analysis of mitochondrial presequence receptor Tom20 in complexes with a presequence from aldehyde dehydrogenase 
Introduction
Most mitochondrial proteins are encoded by the nuclear genome, synthesized in the cytosol and subsequently imported into the mitochondria (Schatz & Dobberstein, 1996) . Mitochondrial protein import across the mitochondrial outer membrane is mediated by a translocator in the outer membranes called TOM (translocase of the outer membrane) complex (Herrmann & Neupert, 2000; Endo et al., 2003; Pfanner et al., 2004) . The TOM is a protein machinery consisting of membrane-protein subunits Tom70, Tom20, Tom22, Tom40 and small Tom subunits (Ahting et al., 1999; Model et al., 2002; Hoogenraad et al., 2002) . Targeting of most proteins destined for the mitochondrial matrix and the inner membrane depends on N-terminal cleavable aminoacid sequences referred to as mitochondrial presequences. A presequence typically consists of about 15-40 amino-acid residues and is rich in positively charged residues (von Heijne, 1986) . The targeting signal in the presequences is recognized by several receptor subunits of the TOM complexes (Bolliger et al., 1995; Pfanner & Chacinska, 2002) , including Tom20 (Muto et al., 2001) . Tom20 is anchored to the outer membrane by the N-terminal hydrophobic segment and exposes a receptor domain to the cytosol.
We determined the solution structure of the cytosolic domain (residues 51-145) of rat Tom20 in a complex with a presequence peptide derived from rat mitochondrial aldehyde dehydrogenease (ALDH) by NMR spectroscopy (Abe et al., 2000) . The NMR structure determination, however, suffered from the fast exchange of the presequence peptide between the free and bound states, which was a major cause of the insufficient number of NOE data between the peptide and Tom20 and within the peptide.
We therefore designed a 68-residue fragment that corresponds to the core structure (residues 59-126) of the cytosolic domain of Tom20 based on the NMR structure. This fragment contains a single cysteine residue. By adding a cysteine residue at the C-terminus of the presequence peptide with a suitable linker, the presequence peptide was fixed onto Tom20 through an intermolecular disulfide bond. The length of the linker was optimized by a novel peptide-library approach (Obita et al., 2003) . In the present research, we have carried out the crystallization and preliminary X-ray crystallographic analysis of the core structure of rat Tom20 complexed with a presequence peptide from rat ALDH tethered by a designer intermolecular disulfide bond.
Materials and methods

Expression and purification of Tom20core
The core structure of the cytosolic domain of Tom20 (Tom20core) encompassing amino acids Asp59-Leu126 from Rattus norvegicus (accession No. Q62760) was produced as a GST-fusion protein in Escherichia coli BL21(DE3) cells (Novagen) using the BamHI and EcoRI restriction sites of the pGEX 2T and pGEX 6P1 vectors (Amersham Biosciences). pGEX 2T encodes the recognition sequence for site-specific cleavage by thrombin, whereas pGEX 6P1 contains the recognition sequence of PreScission protease (Amersham Biosciences). Tom20core has an extra Gly-Ser sequence at the N-terminus after thrombin cleavage and a Gly-Pro-Leu-Gly-Ser sequence after PreScission protease cleavage. They are referred to as GS-Tom20 and GPLGS-Tom20 where necessary.
The transformed E. coli cells were cultured at 310 K in LB media containing 50 mg l À1 ampicillin. After OD 600 reached 0.5, the culture was cooled to 293 K and supplemented with 0.5 mM IPTG. After overnight induction, the cells were harvested by centrifugation. The cell pellets were resuspended in lysis buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM DTT) and disrupted by sonication. The cell lysate was gently stirred with glutathione Sepharose 4B resin (Amersham Biosciences) previously equilibrated with lysis buffer. The affinity resin was packed in a column and washed with the same buffer. The GST-fusion protein was eluted from the resin with buffer containing 20-40 mM reduced glutathione and digested with thrombin [10:1(w:w), Wako Pure Chemicals] at 303 K for 12 h or PreScission protease [100:1(w:w) Amersham Biosciences] at 277 K for 12 h. The resulting protein mixture was applied onto a reversephase HPLC column (Cosmosil 5C4-AR-300, Nacalai Tesque) previously equilibrated with 0.1% TFA and 50% acetonitrile. The protein was eluted with a linear gradient of acetonitrile from 40 to 55% in 25 min at a flow rate of 1 ml min À1 . The fractions containing Tom20core were concentrated by ultrafiltration (5 kDa cutoff, Amicon Ultra, Millipore) in 0.1 M Tris-HCl buffer pH 8.0 containing 0.15 M NaCl. The typical yield was 5-10 mg per litre of culture. Selenomethionine (SeMet) Tom20core was expressed from the BL21(DE3) strain in minimal medium containing seleno-l-methionine at a concentration of 25 mg l
À1
. SeMet Tom20core was purified following the same procedure described above and MALDI-TOF mass spectrometry of the purified protein confirmed the incorporation of selenium.
Presequence peptides
Peptides were obtained by custom peptide synthesis from Qiagen. The unpurified grade peptides were >95% pure and were used without further purification. The peptide sequence is Gly-Pro-ArgLeu-Ser-Arg-Leu-Leu-Ser-X-Ala-Gly-Cys with an N-terminal free amine and a C-terminal amide. The sequence in bold is derived from the presequence (pALDH) of rat mitochondrial ALDH enzyme (accession No. P11884). Two peptides were designed: the Y-linker peptide (pALDH-Y-linker) contains a Tyr residue and the A-linker peptide (pALDH-A-linker) contains an Ala residue at the X position, respectively. The C-terminal amidation is necessary for efficient disulfide-bond formation.
Preparation of disulfide-bond tethered complexes
CuCl 2 was added to the Tom20core solution (0.1 M Tris-HCl pH 8.0, 0.15 M NaCl) to a final concentration of 10 mM. A 20% molar excess of the presequence peptide was then added to the solution. The intermolecular disulfide bond between Tom20core and the presequence peptide was formed through air-oxidation at ambient temperature for 24 h. The formation of the disulfide bond was nearly complete and no free Tom20core remained. The resulting disulfidebonded complex was purified by reverse-phase chromatography in the same way as Tom20core and concentrated by ultrafiltration to 18 mg ml À1 for the native GS-Tom20-SS-pALDH-Y-linker complex in storage buffer (20 mM MOPS pH 7.0, 50 mM NaCl), 40 mg ml
À1
for the SeMet-derivatized GS-Tom20-SS-pALDH-Y-linker complex in storage buffer (10 mM HEPES pH 7.5, 150 mM NaCl) and 17 mg ml À1 for the SeMet GPLGS-Tom20-SS-pALDH-A-linker complex in storage buffer (10 mM HEPES pH 7.5). Note that the choices of protein concentration (17-40 mg ml À1 ), buffer (HEPES or MOPS), pH (7.0 or 7.5) and salt concentration (0-150 mM) were not relevant to successful crystallization.
Crystallization
Initial screening was carried out using the sitting-drop vapourdiffusion method in 96-well Intelli-plates (Art Robbins Instruments) and optimization was performed using the hanging-drop vapourdiffusion method in 24-well VDX greased plates (Hampton Research). Sitting drops were set up by mixing equal volumes (0.2 ml each) of the protein solution and reservoir solution using an automated dispenser (Hydra II Plus-One system, Apogent Discoveries), whereas hanging drops were prepared manually by mixing 2 ml of the protein solution and 1 ml of reservoir solution. Each sitting drop was placed over 0.1 ml reservoir solution and each hanging drop was placed over 0.4 ml reservoir solution. All crystallizations were carried out at 293 K.
Results
Crystallization
The crystallization screening kits used were Crystal Screens 1 and 2, Grid Screen Polyethylene Glycol 6000, (Fig. 1a) .
Data collection
A crystal of the SeMet complex with the A-linker was cryoprotected by a gradual increase of ethylene glycol up to 15% in 3% steps and transferred frozen to the nitrogen-gas stream (100 K). The crystal diffracted to 1.9 Å at BL40B2, SPring-8 (Harima, Japan). A crystal of the SeMet complex with the Y-linker was processed in the same manner and diffracted to 2.8 Å at BL40B2. In contrast, crystals of the native complex with the Y-linker diffracted poorly to 3-8 Å . We succeeded in improving the diffraction resolution to 2.1 Å by crystal dehydration and subsequent annealing. Briefly, the hanging drop containing the crystals was equilibrated against 0.4 ml dehydrating solution (0.1 M HEPES pH 7.0, 25% PEG 6000, 1 M NH 4 Cl) for 10 h at 293 K (Fig. 1b) . The crystals were then briefly dipped into cryoprotectant solution consisting of dehydrating solution and 15% glycerol and cryocooled at 100 K. At this stage crystals diffracted to about 3 Å , but with streaky diffraction spots (Fig. 2a) . A crystal was removed from the nitrogen-gas stream, soaked in a drop of the dehydrating solution containing 15% glycerol for 3 min and then flash-cooled again in the nitrogen-gas stream. This annealing treatment improved the diffraction quality to a resolution of 2.1 Å at BL41XU, SPring-8 (Fig. 2b) .
The diffraction data sets were collected using 2. were indexed and scaled with HKL2000 (Otwinowski & Minor, 1997) . The data-collection statistics are summarized in Table 1 . The space group was C2 for the Y-linker crystals and P2 1 for the A-linker crystal, respectively.
Discussion
We succeeded in obtaining two crystal forms of the complex of the 68-residue receptor domain of rat Tom20 and a presequece peptide derived from rat mitochondrial ALDH enzyme. The presequence binds to Tom20 weakly, which prevented us from obtaining complex crystals by simple mixing of the two molecules. Therefore, we introduced a disulfide bond between the protein and the peptide to stabilize the complex. This trick had been successfully used to analyze the presequence recognition of Tom20; a reasonable pattern of the amino-acid preference of Tom20 was obtained (Obita et al., 2003) , which indicates that this strategy works well to fix the peptide into the binding groove of Tom20 in an unbiased manner. For the crystals of the native Tom20-SS-pALDH-Y-linker complex, crystal dehydration (Heras et al., 2003) and subsequent annealing treatment (Samygina et al., 2000) was essential to obtain diffraction data of high quality for structure determination. Although we attempted to carry out molecular replacement using the NMR structure, no meaningful solution was obtained. A starting model was obtained by the MAD method from the data set of SeMet Tom20-SS-pALDH-Y-linker, which was subsequently used to solve the structure of the SeMet Tom20-SSpALDH-A-linker by molecular replacement. The structure of native Tom20-SS-pALDH-Y-linker was determined by molecular replacement with a model of the SeMet Tom20-SS-pALDH-A-linker. The detailed structure description will be published elsewhere.
